BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22054800)

  • 1. Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.
    Koral K; Roy D; Timmons CF; Gargan L; Bowers DC
    Acad Radiol; 2012 Jan; 19(1):35-9. PubMed ID: 22054800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
    Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children.
    Smoll NR; Drummond KJ
    J Clin Neurosci; 2012 Nov; 19(11):1541-4. PubMed ID: 22981874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood.
    Trojanowski JQ; Fung KM; Rorke LB; Tohyama T; Yachnis AT; Lee VM
    Mol Chem Neuropathol; 1994; 21(2-3):219-39. PubMed ID: 8086035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results.
    McNeil DE; Coté TR; Clegg L; Rorke LB
    Med Pediatr Oncol; 2002 Sep; 39(3):190-4. PubMed ID: 12210449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report].
    Sato H; Shibuya K; Koizumi T; Kato S; Endo S
    No Shinkei Geka; 2014 Jul; 42(7):641-50. PubMed ID: 25006105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
    Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
    Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
    King AA; Seidel K; Di C; Leisenring WM; Perkins SM; Krull KR; Sklar CA; Green DM; Armstrong GT; Zeltzer LK; Wells E; Stovall M; Ullrich NJ; Oeffinger KC; Robison LL; Packer RJ
    Neuro Oncol; 2017 May; 19(5):689-698. PubMed ID: 28039368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth weight and subsequent risk of childhood primary brain tumors: An updated meta-analysis.
    Dahlhaus A; Prengel P; Spector L; Pieper D
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27804208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.
    Bakish J; Hargrave D; Tariq N; Laperriere N; Rutka JT; Bouffet E
    Cancer; 2003 Sep; 98(5):1014-20. PubMed ID: 12942570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma.
    Ho DM; Hsu CY; Wong TT; Ting LT; Chiang H
    Acta Neuropathol; 2000 May; 99(5):482-8. PubMed ID: 10805090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
    Inda MM; Muñoz J; Coullin P; Fauvet D; Danglot G; Tuñón T; Bernheim A; Castresana JS
    Histopathology; 2006 Apr; 48(5):579-87. PubMed ID: 16623784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Gajjar A; Boyett JM; Walter AW; Thompson SJ; Merchant TE; Jenkins JJ; Langston JW; Liu A; Kun LE; Heideman RL
    J Clin Oncol; 1999 Oct; 17(10):3234-7. PubMed ID: 10506624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.